N-substituted pyrrolidine methylphosphates and methylphosponates as DNPH1 inhibitors

WO2026142431A1PCT designated stage Publication Date: 2026-07-02ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIV
Filing Date
2025-12-23
Publication Date
2026-07-02

Smart Images

  • Figure NZ2025050114_02072026_PF_FP_ABST
    Figure NZ2025050114_02072026_PF_FP_ABST
Patent Text Reader

Abstract

Compounds of the Formula (I), pharmaceutical compositions comprising compounds of the Formula (I), and their use for treating or preventing cancer: (I)
Need to check novelty before this filing date? Find Prior Art